The creation of a drug consists of a copious and complicated series of projects that are all intertwined.  Andy Mehrotra, CEO of Unipr, joins the Patient Empowerment Program to discuss how Unipr’s AI based cloud program, project, and portfolio management platforms allow organizations like n-Lorem to quickly analyze data to inform program management. Today, n-Lorem effectively manages more than 90 accepted patient programs thanks to help from Unipr. Discovering locations where productivity can be increased while maintaining quality in every step is critical to treating as many nano-rare patients as possible.   On This Episode We Discuss: Andy’s upbringing among physicians and pharmaceutical entrepreneurs Traveling the world to launch Humera Baring the frigid Boston winters at MIT Inspiration to found Unipr How biotech and pharmaceutical organizations can use Unipr to increase efficiency The partnership between Unipr and n-Lorem Unipr’s focus areas: Increasing the probability of success, decreasing the operational costs, and decreasing the cycle time for drug development Why Andy would donate himself to help n-Lorem